Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Claire Roddie

Claire Roddie


Academic history

Claire Roddie, MD, PhD, is a Consultant Haematologist at the University College London Hospitals NHS Foundation Trust, London, UK, and Honorary Senior Lecturer in Haematology at University College London, London, UK.

Speaking on cellular therapies for hematologic malignancies

Dr Roddie’s main research interest is cellular therapies, primarily chimeric antigen receptor (CAR) T-cell therapy for the treatment of hematologic malignancies. Dr Roddie’s recent involvements include publications on the clinical outcomes and risk factors for COVID-19 in patients with hematological disorders and she is currently leading the Phase I CAROUSEL trial (NCT04443829) on CD19-targeting CAR T-cells for relapsed/refractory primary CNS lymphoma.